1887

Abstract

In this study we have analysed variability in the V1 and V2 regions of human immunodeficiency virus type 1 (HIV-1) proviral sequences amplified from lymphoid tissue, brain and other non-lymphoid tissue collected at autopsy from three HIV-1-infected individuals with giant cell encephalitis. We found no evidence for any tissue-specific grouping of variants in the V1/V2 regions, in contrast to previous comparisons of sequences in the V3 region, but consistent with the existence of evolu- tionarily distinct lineages previously observed in these study subjects by sequence comparisons of the p17 gene. Examination of inferred amino acid sequences from V1 and V2 revealed no correlations between tissue origin with overall charge, length or number of glycosylation sites. Length polymorphism analysis is a rapid method to compare whole populations of HIV-1 variants within a sample, and provides information on the length and diversity of the V1 and V2 hypervariable regions. Based upon a comparison of 42 individuals with CD4 counts ranging from 802 to < 1 at time of death, we found no evidence for changes in the length of V2 with development of AIDS. Using the number of length variants in the V1 and V2 hypervariable region as a marker of the overall degree of variability within HIV populations, we found no evidence for an increase or a decrease in diversity between those with and without AIDS defining illness.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-11-2871
1997-11-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/11/9367374.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-11-2871&mimeType=html&fmt=ahah

References

  1. Andeweg A. C., Leeflang P., Osterhaus A. D. M. E., Bosch M. L. 1993; Both the V2 and V3 regions of the human immunodeficiency virus type-1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. Journal of Virology 67:3232–3239
    [Google Scholar]
  2. Bernstein H. B., Tucker S. P., Hunter E., Schutzbach J. S., Compans R. W. 1994; Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. Journal of Virology 68:463–468
    [Google Scholar]
  3. Chesebro B., Wehrly K., Nishio J., Perryman S. 1992; Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T cell-tropic isolates: definition of critical amino acids involved in cell tropism. Journal of Virology 66:6547–6554
    [Google Scholar]
  4. Cornelissen M., Hogervorst E., Zorgdrager F., Hartman S., Goudsmit J. 1995; Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites. AIDS Research and Human Retroviruses 11:1169–1175
    [Google Scholar]
  5. Donaldson Y. K., Bell J. E., Holmes E. C., Hughes E. S., Brown H. K., Simmonds P. 1994a; In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. Journal of Virology 68:5991–6005
    [Google Scholar]
  6. Donaldson Y. K., Bell J. E., Ironside J. W., Brettle R. P., Robertson J. R., Busuttil A., Simmonds P. 1994b; Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 343:382–385
    [Google Scholar]
  7. Felsenstein J. 1989; PHYLIP-phylogeny inference package (version 3.2). Cladistics 5:164–166
    [Google Scholar]
  8. Fouchier R. A. M., Broersen S. M., Brouwer M., Tersmette M., Vantwout A. B., Groenink M., Schuitemaker H. 1995; Temporal relationship between elongation of the HIV type 1 glycoprotein 120 V2 domain and the conversion toward a syncytium-inducing phenotype. AIDS Research and Human Retroviruses 11:1473–1478
    [Google Scholar]
  9. Fung M. S., Sun C. R., Gordon W. L., Liou R. S., Chang T. W., Sun W. N., Daar E. S., Ho D. D. 1992; Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. Journal of Virology 66: 848–856
    [Google Scholar]
  10. Ganeshan S., Dickover R. E., Korber B. T. M., Bryson Y. J., Wolinsky S. M. 1997; Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. Journal of Virology 71:663–677
    [Google Scholar]
  11. Gram G. J., Hemming A., Bolmstedt A., Jansson B., Olofsson S., Akerblom L., Nielsen J. O., Hansen J. E. S. 1994; Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Archives of Virology 139:253–261
    [Google Scholar]
  12. Groenink M., Fouchier R. A. M., Broersen S., Baker C. H., Koot M., Van’t Wout A. B., Huisman H. G., Miedema F., Tersmette M., Schuitemaker H. 1993; Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 260:1513–1516
    [Google Scholar]
  13. Hansen J. E., Nielsen C., Arendrup M., Olofsson S., Mathiesen L., Nielsen J. O., Clausen H. 1991; Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus type 1. Journal of Virology 65:6461–6467
    [Google Scholar]
  14. Hughes E. S., Bell J. E., Simmonds P. 1997; Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. Journal of Virology 71:1272–1280
    [Google Scholar]
  15. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R. 1991; Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71–74
    [Google Scholar]
  16. Jentoft N. 1990; Why are proteins O-glycosylated?. Trends in Biochemical Sciences 15:291–294
    [Google Scholar]
  17. Kasper P., Simmonds P., Schneweis K. E., Kaiser R., Matz B., Oldenburg J., Brackmann H. H., Holmes E. C. 1995; The genetic diversification of the HIV type 1 gag p17 gene in patients infected from a common source. AIDS Research and Human Retroviruses 11:1197–1201
    [Google Scholar]
  18. Koito A., Harrowe G., Levy J. A., Chengmayer C. 1994; Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. Journal of Virology 68:2253–2259
    [Google Scholar]
  19. Korber B. T. M., Kunstman K. J., Patterson B. K., Furtado M., McEvilly M. M., Levy R., Wolinsky S. M. 1994; Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. Journal of Virology 68: 7467–7481
    [Google Scholar]
  20. Kumar S., Tamura K., Nei M. 1993 MEGA: Molecular Evolutionary Genetics Analysis version 1.0 University Park: The Pennsylvania State University;
    [Google Scholar]
  21. Lamers S. L., Sleasman J. W., She J. X., Barrie K. A., Pomeroy S. M., Barrett D. J., Goodenow M. M. 1993; Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type-1 in vivo. Journal of Virology 67:3951–3960
    [Google Scholar]
  22. Leonard C. K., Spellman M. W., Riddle L., Harris R. J., Thomas J. N., Gregory T. J. 1990; Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. Journal of Biological Chemistry 265:10373–10382
    [Google Scholar]
  23. Li W. H., Tanimura M., Sharp P. M. 1988; Rates and dates of divergence between AIDS virus nucleotide sequences. Molecular Biology and Evolution 5:313–330
    [Google Scholar]
  24. Lukashov V. V., Kuiken C. L., Goudsmit J. 1995; Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. Journal of Virology 69:6911–6916
    [Google Scholar]
  25. McKeating J. A., Shotton C., Cordell J., Graham S., Balfe P., Sullivan N., Charles M., Page M., Bolmstedt A., Olofsson S., Kayman S. C., Wu Z., Pinter A., Dean C., Sodroski J., Weiss R. A. 1993; Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the 1st and 2nd variable domains of human immunodeficiency virus type-1 gp120. Journal of Virology 67:4932–4944
    [Google Scholar]
  26. Moore J. P., Sattentau Q. J., Yoshiyama H., Thali M., Charles M., Sullivan N., Poon S. W., Fung M. S., Traincard F., Pinkus M., Robey G., Robinson J. E., Ho D. D., Sodroski J. 1993; Probing the structure of the V2-domain of human immunodeficiency virus type-1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies - human immune response to the V1-domain and V2-domain. Journal of Virology 67:6136–6151
    [Google Scholar]
  27. Nowak M. A., Anderson R. M., McLean A. R., Wolfs T. F. W., Goudsmit J., May R. M. 1991; Antigenic diversity thresholds and the development of AIDS. Science 254:963–969
    [Google Scholar]
  28. Palmer C., Balfe P., Fox D., May J. C., Frederiksson R., Fenyo E. M., McKeating J. A. 1996; Functional characterization of the V1/V2 region of human immunodeficiency virus type 1. Virology 220:436–449
    [Google Scholar]
  29. Phillips R. E., Rowland Jones S., Nixon D. F., Gotch F. M., Edwards J. P., Ogunlesi A. O., Elvin J. G., Rothbard J. A., Bangham C. R., Rizza C. R. 1991; Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453–459
    [Google Scholar]
  30. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. 1988; The brain in AIDS: central nervous system HIV-1 and AIDS dementia complex. Science 239:586–592
    [Google Scholar]
  31. Reddy R. T., Achim C. L., Sirko D. A., Tehranchi S., Kraus F. G., Wongstaal F., Wiley C. A., Grant I., Atkinson J. H., Kelly M., Chandler J. L., Wallace M. R., McCutchan J. A., Spector S. A., Thal L., Heaton R. K., Hesselink J., Jernigan T., Masliah E., Abramson I., Butters N., Patterson T., Zisook S., Jeste D. 1996; Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Research and Human Retroviruses 12:477–482
    [Google Scholar]
  32. Shioda T., Levy J. A., Cheng-Mayer C. 1992; Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell line and macrophage tropism of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 89:9434–9438
    [Google Scholar]
  33. Shioda T., Oka S., Ida S., Nokihara K., Toriyoshi H., Mori S., Takebe Y., Kimura S., Shimada K., Nagai Y. 1994; A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. Journal of Virology 68:7689–7696
    [Google Scholar]
  34. Simmonds P., Balfe P., Ludlam C. A., Bishop J. O., Leigh Brown A. J. 1990a; Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. Journal of Virology 64:5840–5850
    [Google Scholar]
  35. Simmonds P., Balfe P., Peutherer J. F., Ludlam C. A., Bishop J. O., Leigh Brown A. J. 1990b; Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. Journal of Virology 64:864–872
    [Google Scholar]
  36. Simmonds P., Zhang L. Q., McOmish F., Balfe P., Ludlam C. A., Leigh Brown A. J. 1991; Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. Journal of Virology 65: 6266–6276
    [Google Scholar]
  37. Toohey K., Wehrly K., Nishio J., Perryman S., Chesebro B. 1995; Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213:70–79
    [Google Scholar]
  38. van Tijn D. A., Boucher C. A., Bakker M., Goudsmit J. 1989; Antigenicity of linear B-cell epitopes in the C1, V1, and V3 region of HIV-1 gp 120. Journal of Acquired Immune Deficiency Syndromes 2:303–306
    [Google Scholar]
  39. Vazeux R., Brousse N., Jarry A., Henin D., Marche C., Vedrenne C., Mikol J., Wolff M., Michon C., Rozenbaum L., Brahic M. 1987; AIDS subacute encephalitis: identification of HIV infected cells. American Journal of Pathology 126:403–410
    [Google Scholar]
  40. Wang N., Zhu T. F., Ho D. D. 1995; Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype. Journal of Virology 69:2708–2715
    [Google Scholar]
  41. Warrier S. V., Pinter A., Honnen W. J., Girard M., Muchmore E., Tilley S. A. 1994; A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gpr120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody. Journal of Virology 68:4636–4642
    [Google Scholar]
  42. Wei X. P., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H., Saag M. S., Shaw G. M. 1995; Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117–122
    [Google Scholar]
  43. Wolinsky S. M., Korber B. T. M., Neumann A. U., Daniels M., Kunstman K. J., Whetsell A. J., Furtado M. R., Cao Y. Z., Ho D. D., Safrit J. T., Koup R. A. 1996; Adapt ive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537–542
    [Google Scholar]
  44. Wong J., Ignacio C., Torriani F., Havlir D., Fitch N. J. S., Richman D. D. 1997; In vivo compartmentalization of human immunodeficiency virus : evidence from the examination of pol sequences from autopsy tissues. Journal of Virology 71:2059–2071
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-11-2871
Loading
/content/journal/jgv/10.1099/0022-1317-78-11-2871
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error